AT355739B - Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2 - Google Patents
Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2Info
- Publication number
- AT355739B AT355739B AT310177A AT310177A AT355739B AT 355739 B AT355739 B AT 355739B AT 310177 A AT310177 A AT 310177A AT 310177 A AT310177 A AT 310177A AT 355739 B AT355739 B AT 355739B
- Authority
- AT
- Austria
- Prior art keywords
- desoxy
- prostaglandin
- producing new
- new derivatives
- derivatives
- Prior art date
Links
- 229960001342 dinoprost Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- PXGPLTODNUVGFL-YNNPMVKQSA-N prostaglandin F2alpha Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O PXGPLTODNUVGFL-YNNPMVKQSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7612942A FR2349328A1 (fr) | 1976-04-30 | 1976-04-30 | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
| FR7701299A FR2377395A2 (fr) | 1977-01-18 | 1977-01-18 | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA310177A ATA310177A (de) | 1979-08-15 |
| AT355739B true AT355739B (de) | 1980-03-25 |
Family
ID=26219428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT310177A AT355739B (de) | 1976-04-30 | 1977-05-02 | Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4119727A (de) |
| JP (1) | JPS52148048A (de) |
| AR (1) | AR222627A1 (de) |
| AT (1) | AT355739B (de) |
| AU (1) | AU511408B2 (de) |
| CA (1) | CA1100493A (de) |
| CH (1) | CH620675A5 (de) |
| DE (1) | DE2719244A1 (de) |
| DK (1) | DK187677A (de) |
| GB (1) | GB1538842A (de) |
| IE (1) | IE45141B1 (de) |
| LU (1) | LU77240A1 (de) |
| NL (1) | NL7704758A (de) |
| SE (1) | SE436037B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282901U (de) * | 1988-12-12 | 1990-06-27 | ||
| US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| WO2005081960A2 (en) * | 2004-02-25 | 2005-09-09 | Wyeth | Inhibitors of protein tyrosine phosphatase 1b |
| WO2005081954A2 (en) | 2004-02-25 | 2005-09-09 | Wyeth | Inhibitors of protein tyrosine phosphatase 1b |
| US7906552B2 (en) | 2004-08-10 | 2011-03-15 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7183310B2 (en) | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| DE602006013945D1 (de) * | 2005-01-14 | 2010-06-10 | Allergan Inc | Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck |
| JP5213448B2 (ja) * | 2005-03-04 | 2013-06-19 | スキャンポ・アーゲー | 末梢血管疾患の処置のための方法および組成物 |
| CA2628413C (en) | 2005-11-03 | 2014-09-23 | Allergan, Inc. | Prostaglandins and analogues as agents for lowering intraocular pressure |
| EP2291346A2 (de) * | 2008-05-15 | 2011-03-09 | Allergan, Inc. | Therapeutische substituierte cyclopentane |
| US9695254B2 (en) | 2012-11-26 | 2017-07-04 | Braskem S.A. | Metallocene catalyst supported by hybrid supporting means, process for producing same, polymerization process for producing an ethylene homopolymer or copolymer with broad or bimodal molar mass distribution, use of the supported metallocene catalyst and ethylene polymer with broad or bimodal molar mass distribution |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3776940A (en) * | 1966-08-09 | 1973-12-04 | G Just | Intermediates for producing prostaglandins |
| US3956284A (en) * | 1972-07-13 | 1976-05-11 | Pfizer Inc. | Heterocyclic 15-substituted-ω-pentanorprostoglandins |
| US3794664A (en) * | 1972-08-17 | 1974-02-26 | G Just | Bicyclo(3.1.0)hexane intermediates for producing prostaglandins f1alpha and f1beta |
| US4387241A (en) * | 1974-11-01 | 1983-06-07 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
-
1977
- 1977-04-21 SE SE7704616A patent/SE436037B/xx not_active IP Right Cessation
- 1977-04-29 CA CA277,423A patent/CA1100493A/fr not_active Expired
- 1977-04-29 CH CH541177A patent/CH620675A5/fr not_active IP Right Cessation
- 1977-04-29 NL NL7704758A patent/NL7704758A/xx not_active Application Discontinuation
- 1977-04-29 GB GB18082/77A patent/GB1538842A/en not_active Expired
- 1977-04-29 AR AR267416A patent/AR222627A1/es active
- 1977-04-29 DE DE19772719244 patent/DE2719244A1/de active Granted
- 1977-04-29 DK DK187677A patent/DK187677A/da not_active Application Discontinuation
- 1977-04-30 JP JP5061277A patent/JPS52148048A/ja active Granted
- 1977-05-02 AT AT310177A patent/AT355739B/de not_active IP Right Cessation
- 1977-05-02 IE IE885/77A patent/IE45141B1/en unknown
- 1977-05-02 AU AU24795/77A patent/AU511408B2/en not_active Expired
- 1977-05-02 US US05/792,563 patent/US4119727A/en not_active Expired - Lifetime
- 1977-05-03 LU LU77240A patent/LU77240A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE45141B1 (en) | 1982-06-30 |
| ATA310177A (de) | 1979-08-15 |
| DE2719244A1 (de) | 1977-11-17 |
| SE7704616L (sv) | 1977-10-31 |
| DK187677A (da) | 1977-10-31 |
| JPS6131103B2 (de) | 1986-07-17 |
| DE2719244C2 (de) | 1987-10-15 |
| NL7704758A (nl) | 1977-11-01 |
| US4119727A (en) | 1978-10-10 |
| LU77240A1 (de) | 1977-12-13 |
| JPS52148048A (en) | 1977-12-08 |
| AU511408B2 (en) | 1980-08-21 |
| AU2479577A (en) | 1978-11-09 |
| CA1100493A (fr) | 1981-05-05 |
| GB1538842A (en) | 1979-01-24 |
| SE436037B (sv) | 1984-11-05 |
| AR222627A1 (es) | 1981-06-15 |
| CH620675A5 (de) | 1980-12-15 |
| IE45141L (en) | 1977-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT374495B (de) | Verfahren zur herstellung neuer derivate der verbindung ml-236b | |
| AT350182B (de) | Verfahren zur herstellung neuer alkyloxim- derivate der 7-amino-thiazolyl-acetamido- cephalosporansaeure | |
| AT353428B (de) | Verfahren zur herstellung neuer quartaerer n- beta-substituierter benzilsaeure-n-alkyl- -nortropinester | |
| DD122972A5 (de) | Verfahren zur herstellung neuer derivate der 3-chinolinkarbonsaeure | |
| AT355739B (de) | Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2 | |
| DD135489A5 (de) | Verfahren zur herstellung neuer derivate des alkylendiamins | |
| PL197005A1 (pl) | Sposob wytwarzania nowych pochodnych prostaglandyn | |
| AT352918B (de) | Verfahren zur herstellung neuer histidin- derivate | |
| AT370109B (de) | Verfahren zur herstellung neuer acetylenderivate des androst-4-ens | |
| DD131020A5 (de) | Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen | |
| DD131021A5 (de) | Verfahren zur herstellung substituierter aminochinazolinderivate | |
| DD128130A5 (de) | Verfahren zur herstellung neuer pyrazol-derivate | |
| AT357155B (de) | Verfahren zur herstellung neuer imidazol- derivate | |
| AT368520B (de) | Verfahren zur herstellung neuer azetylenderivate des androst-4-ens | |
| AT358202B (de) | Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons | |
| AT365601B (de) | Verfahren zur herstellung neuer derivate von 4- | |
| ATA508376A (de) | Verfahren zur herstellung neuer 1-methyl-2- (phenyl-oxymethyl)-5-nitroimidazolderivate | |
| AT363933B (de) | Verfahren zur herstellung neuer derivate des(1, 3)-benzodioxins | |
| DD128774A5 (de) | Verfahren zur herstellung neuer quartaerer derivate von sandwicin | |
| AT355028B (de) | Verfahren zur herstellung neuer salze des 1,3- bis-(beta-aethylhexyl)-5-amino-5-methyl- hexahydropyrimidins | |
| ATA783078A (de) | Verfahren zur hertellung neuer derivate des eburnamenins | |
| ATA845475A (de) | Verfahren zur herstellung neuer prostaglandin- analoge | |
| AT357276B (de) | Verfahren zur herstellung des prostaglandins a2 und bestimmter derivate desselben | |
| AT363622B (de) | Verfahren zur herstellung neuer derivate des pregn-4-ens | |
| AT356089B (de) | Verfahren zur herstellung neuer derivate der 4-cyclohexyl-1-naphthalinessigsaeure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |